Drug intelligence / Profile preview

Multivitamin D

Development stage: Unknown
Lead developer: PharmaS
Administration: Oral

Overview

Multivitamin D is a dietary supplement developed and marketed by PharmaS, a Croatian pharmaceutical and consumer health company. It is formulated to support the immune system and maintain bone health, primarily by providing Vitamin D3 (cholecalciferol) in combination with other essential vitamins. As a consumer health product, it is intended to supplement the daily diet in individuals with increased nutritional needs or reduced intake. The product is part of PharmaS's broader consumer health portfolio, which includes other supplements such as Magnezij Citrat and Imuno CD, and is primarily distributed in the Adriatic region.

Brand names: Multivitamin D
Other names: PharmaS Multivitamin D

Targets

PDIA3 (Membrane-associated rapid response steroid-binding receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Multivitamin D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multivitamin D.

Explore the full profile